Mobile Health Technology for Atrial Fibrillation
(mTECH Afib Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if the Corrie Virtual Atrial Fibrillation Management Program, a new digital tool, can help people with atrial fibrillation (AFib) manage their condition more effectively and improve their quality of life. The tool educates patients about treatment options and assists them in coping during AFib episodes, which can cause anxiety. Participants will either use this digital program or continue with their usual care to compare results. Individuals with AFib lasting less than seven days at a time or ongoing for seven days or more, and with a BMI of 27 or higher, might be suitable candidates. As an unphased trial, this study provides a unique opportunity to explore innovative digital health solutions for managing AFib.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this digital atrial fibrillation management tool is safe?
Research has shown that digital health programs like the Corrie Virtual Atrial Fibrillation Management Program are generally safe for users. Although specific safety data for this exact program is not available, similar virtual health programs have been tested and found to be well-tolerated by patients.
This trial is in a phase called "not applicable," which typically means the treatment isn't a new drug or surgery, often indicating lower risk. Digital tools and programs generally pose less risk of physical side effects compared to medications or surgeries.
Participants using the Corrie program in related studies have not reported significant negative effects. This suggests it is likely safe for managing atrial fibrillation (AFib), a condition affecting the heart's rhythm. It is important to consult a healthcare provider to understand any personal risks.12345Why are researchers excited about this trial?
Researchers are excited about the Corrie Virtual Atrial Fibrillation Management Program because it's a novel approach that leverages mobile health technology to manage atrial fibrillation. Unlike traditional treatments, which often involve medication or invasive procedures, this program offers a virtual, multicomponent management system. It enhances patient engagement and self-management through digital tools, potentially improving adherence and outcomes. This approach could represent a significant shift in how atrial fibrillation is managed, making care more accessible and personalized.
What evidence suggests that the Corrie Virtual Atrial Fibrillation Management Program is effective for improving quality of life in AFib patients?
Research has shown that the Corrie Virtual Atrial Fibrillation Management Program, which participants in this trial may receive, might help people with atrial fibrillation (AFib) live better lives. Studies indicate that many people continued using the app and participated in virtual coaching sessions, demonstrating high engagement. An initial study found that this virtual self-management approach could improve condition management and mental health. By helping patients take control of their AFib, the program aims to reduce anxiety and boost overall well-being. These early results suggest that the digital toolkit could be a promising option for those living with AFib.12678
Who Is on the Research Team?
David Spragg, MD
Principal Investigator
Johns Hopkins University
Are You a Good Fit for This Trial?
This trial is for adults aged 18 or older who have been diagnosed with paroxysmal (AFib lasting less than 7 days) or persistent atrial fibrillation (lasting 7 days or longer), and have a BMI of 27.0 or higher.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants use a comprehensive digital atrial fibrillation management tool to learn about AFib management options and adhere to therapies and lifestyle changes
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Corrie Virtual Atrial Fibrillation Management Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
Apple Inc.
Industry Sponsor
PhRMA Foundation
Collaborator
Itamar-Medical, Israel
Industry Sponsor
Pharmaceutical Research & Manufacturers Of America Foundation
Collaborator